l General Information |
Product Name | ZCL278 |
General description | ZCL278 is a selective Cdc42 GTPase inhibitor. |
Synonym | 2-(4-bromo-2-chlorophenoxy)-N-[[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenyl]carbamothioyl]acetamide |
Purity | ≥98.0%(HPLC) | CAS Number | 587841-73-4 |
Formula | C21H19BrClN5O4S2 | Molecular Weight | 584.89 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | ZCL278 is a selective Cdc42 GTPase inhibitor with Kd of 11.4 μM. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
